Merck & Co., Inc. (MRK)
110.96
-0.05
(-0.05%)
USD |
NYSE |
Jan 15, 16:00
110.83
-0.13
(-0.12%)
After-Hours: 19:44
Merck Profit Margin (Quarterly): 33.68% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen, Inc. | 33.55% |
| Gilead Sciences, Inc. | 39.21% |
| Regeneron Pharmaceuticals, Inc. | 38.89% |
| Cidara Therapeutics, Inc. | -- |
| Moderna, Inc. | -19.68% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 39.63% |
| Return on Assets | 15.96% |
| Return on Invested Capital | 22.23% |
| Gross Profit Margin (Quarterly) | 75.59% |
| Operating Margin (Quarterly) | 43.43% |
| Return on Net Operating Assets | 23.77% |